MARKET

CAMRF

CAMRF

Camurus Sweden
OTCPK
58.51
NaN%
Closed 09:30 07/17 EDT
OPEN
--
PREV CLOSE
58.51
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
71.00
52 WEEK LOW
55.00
MARKET CAP
3.48B
P/E (TTM)
48.84
1D
5D
1M
3M
1Y
5Y
1D
Camurus’ Acromegaly Drug CAM2029 Resubmission Accepted by U.S. FDA
TipRanks · 2d ago
Camurus AB Earnings Call Highlights Growth And Risks
TipRanks · 3d ago
Camurus AB (publ) reports results
Seeking Alpha · 4d ago
Camurus Delivers Record Product Sales and Strengthens Cash While Deepening Lilly Collaboration
TipRanks · 4d ago
Camurus Boosts Share Count to Support Employee Incentive Plan
TipRanks · 06/30 05:34
Camurus hit by FDA manufacturing setback on U.S. acromegaly drug filing
TipRanks · 06/10 23:03
Camurus Targets Real‑World Evidence in New Acromegaly Study With Octreotide Depot
TipRanks · 06/04 16:32
Eli Lilly expands collaboration with Camurus to include amylin agonists
Seeking Alpha · 06/01 19:38
More
About CAMRF
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.

Webull offers Camurus AB stock information, including OTCPK: CAMRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CAMRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CAMRF stock methods without spending real money on the virtual paper trading platform.